On Nov 01, major Wall Street analysts update their ratings for $Teleflex (TFX.US)$, with price targets ranging from $245 to $285.
Morgan Stanley analyst Patrick Wood maintains with a buy rating, and maintains the target price at $275.
Mizuho Securities analyst Anthony Petrone maintains with a hold rating, and adjusts the target price from $275 to $250.
Needham analyst Michael Matson maintains with a hold rating.
RBC Capital analyst Shagun Singh Chadha maintains with a buy rating, and adjusts the target price from $275 to $245.
JMP Securities analyst David Turkaly maintains with a buy rating, and maintains the target price at $285.
Furthermore, according to the comprehensive report, the opinions of $Teleflex (TFX.US)$'s main analysts recently are as follows:
Teleflex's third-quarter revenue shortfall is attributed to an unexpected OEM customer departure and a decrease in UroLift performance. Nonetheless, it is maintained that the core business elements of Teleflex remain solid and that it is progressing towards its margin enlargement goals.
The assessment of Teleflex's recent quarterly report is characterized as 'mixed.' The expectation is for the near-term to stay challenging, yet the prospects for the Urology segment, particularly with Pallette's momentum, are seen as promising.
Here are the latest investment ratings and price targets for $Teleflex (TFX.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
